Share
793 Posts.
lightbulb Created with Sketch. 6
clock Created with Sketch.
11/11/14
14:24
Share
Originally posted by Psychiatrist
↑
Hi Valuesnatcher.
If the growth story remains intact over next two to three years, 30-35 cents is also not a bad entry point. I still think it is the shorters covering now and this may test 25 cents again so will give a good entry point.
I would advise you to watch Robert Grey's interview with Alan Kohler on Eureka TV (join free) . He is confident of US revenue doubling every year for next three years. They have some good competitive advantages although I would stop short of calling it a moat.
Lots of sites and software integration should follow for a number of them.
Sitting is the key here IMO. Growth company in health care, earnings are subject to fluctuation due to R and D investments. Conservative accounting: factory costs and R and D all expensed when Factory could have been capitalised.
Expand
Thanks Psy.
Just FYI, reported gross short sale volume was ~750k units for Monday. Volume so far is 8.3M so I'd say any shorts wishing to cover were not a meaningful portion of the rise.